Sharp Rise in Number of Parents Refusing Newborn Vitamin K Shots, Putting Babies at 81-Fold Higher Risk of Severe Bleeding

Key Takeaways

• 5.2% US newborns refused vitamin K in 2024.
• Refusal rate rose 77% since 2017.
• No shot increases VKDB risk 81-fold.
• VKDB kills about 20% of affected infants.
• Trend linked to broader anti‑vaccine movement.

Pulse Analysis

Vitamin K administration at birth has been a cornerstone of neonatal care for decades, preventing vitamin K‑deficient bleeding (VKDB), a condition that can cause catastrophic internal hemorrhage. The JAMA analysis of over five million births confirms that infants who miss the single intramuscular dose are 81 times more likely to develop VKDB, and the mortality rate among those cases hovers around 20%. These stark figures underscore why the injection, though simple, remains a critical safeguard against a rare but lethal disorder.

The latest data reveal a 77 percent jump in refusal rates since 2017, climbing to 5.2 percent of all U.S. births in 2024. Health experts attribute this rise to the spillover of anti‑vaccine sentiment that has proliferated across social media and parent networks. While vitamin K is not a vaccine, its association with the broader discourse on medical autonomy and distrust of health authorities has led some parents to decline the shot alongside routine immunizations. Demographic analyses suggest higher refusal rates in regions with strong political conservatism and lower trust in public health messaging.

Public‑health officials are now grappling with how to reverse the trend without alienating skeptical families. Strategies include targeted education campaigns that clarify the distinct purpose and safety profile of vitamin K, as well as integrating counseling into prenatal visits. Some states are considering policy measures such as mandatory documentation of vitamin K administration before hospital discharge. Addressing the refusal wave is essential not only to protect newborns from VKDB but also to preserve confidence in the broader immunization schedule, which remains vital for controlling preventable childhood diseases.